Salarius Pharmaceuticals
SLRX
SLRX
7 hedge funds and large institutions have $7.55K invested in Salarius Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
AC
1
Armistice Capital
New York
|
$0 |
| 2 |
2
Wells Fargo
San Francisco,
California
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $4.59K | 3,189 | +11 | +0.3% |
|
2
Citigroup
New York
| $2.32K | 1,610 | +1,610 | New |
|
3
UBS Group
Zurich,
Switzerland
| $375 | 260 | +147 | +130% |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $232 | 162 | +109 | +206% |
|
5
Bank of America
Charlotte,
North Carolina
| $26 | 18 | +12 | +200% |
|
6
Morgan Stanley
New York
| $10 | 7 | – | – |
|
7
BlackRock
New York
| $1 | 1 | – | – |
|
|
AC
8
Armistice Capital
New York
| – | – | -22,750 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| – | – | -1 | Closed |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|